Company / Depreciation & Amortization
AbCellera Biologics Inc. Depreciation & Amortization History
FY2019-FY2023 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Depreciation & Amortization
$24.4M
FY2023
5-year range
$1.6M / $24.4M
FY2019-FY2023
Trend
+952.9%
vs FY2022
Sector context
#42 of 163
Health Care
What the data says
Depreciation & Amortization changed +953% YoY in FY2023, a notable deviation from the 4-year average annual change of +253%.
Based on SEC 10-K filings.
$24M in FY2023 with a 3-year CAGR of +119.2%.
Increased from $2M to $24M over the past 2 years.
Health Care sector context is included.
Depreciation & Amortization over time
Growth rates
- 3-Year CAGR
- +119.2%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#122 of 163 in Health CareTop 74% of 163This company $24.4M Sector average $219.4M
▼
-88.9% below sector average
Key checks
Key Insights
- 3-year CAGR of +119.2%, indicating consistent growth.
- In FY2023, depreciation & amortization increased 952.9% year-over-year.
- Ranks #42 out of 163 companies in the Health Care sector.
- Lowest depreciation & amortization in the period was in FY2021.
Company context
Key Data Points
- Altman Z-Score 0.93 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Depreciation & AmortizationValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | - | - |
| FY2023 | $24.4M | +952.9% |
| FY2022 | $2.3M | +44.5% |
| FY2021 | $1.6M | -30.8% |
| FY2020 | $2.3M | +44.5% |
| FY2019 | $1.6M | - |
As of FY2023 · SEC 10-K · Updated Jul 1, 2026